Ibrahim Aldoss, MD - Expanding Bispecific Options for Acute Lymphoblastic Leukemia: From Current Standards to Future Practice

Ibrahim Aldoss, MD - Expanding Bispecific Options for Acute Lymphoblastic Leukemia: From Current Standards to Future Practice

May 29, 2026 · 38 min

About this episode

The episode discusses expanding bispecific treatment options for Acute Lymphoblastic Leukemia and their implications for future practice.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/QKH865. CME/MOC/AAPA credit will be available until May 13, 2027. Expanding Bispecific Options for Acute Lymphoblastic Leukemia: From Current Standards to Future Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent educational grant from AstraZeneca. Disclosure information is available at the beginning of the video presentation.

Sponsors

AstraZeneca

More episodes of PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast

Explore listener stats, chart rankings, contacts and more on the PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast podcast page.